<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">48051</article-id><article-id pub-id-type="doi">10.7554/eLife.48051</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Multiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-139897"><name><surname>Ramaglia</surname><given-names>Valeria</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9401-5988</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-151917"><name><surname>Sheikh-Mohamed</surname><given-names>Salma</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141421"><name><surname>Legg</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-140887"><name><surname>Park</surname><given-names>Calvin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141422"><name><surname>Rojas</surname><given-names>Olga L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141423"><name><surname>Zandee</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141424"><name><surname>Fu</surname><given-names>Fred</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141425"><name><surname>Ornatsky</surname><given-names>Olga</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-140891"><name><surname>Swanson</surname><given-names>Eric C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8454-1207</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-139833"><name><surname>Pitt</surname><given-names>David</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6407-9542</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-66271"><name><surname>Prat</surname><given-names>Alexandre</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6188-0580</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141426"><name><surname>McKee</surname><given-names>Trevor D</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141427"><name><surname>Gommerman</surname><given-names>Jennifer L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution content-type="dept">Department of Immunology</institution>, <institution>University of Toronto</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff2"><institution content-type="dept">Department of Neurology</institution>, <institution>Yale School of Medicine</institution>, <addr-line><named-content content-type="city">New Haven</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Neuroscience</institution>, <institution>Université de Montreal</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><aff id="aff4"><institution content-type="dept">STTARR Innovation center</institution>, <institution>University Health Network</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff5"><institution>Fluidigm Inc</institution>, <addr-line><named-content content-type="city">Markham</named-content></addr-line>, <country>Canada</country></aff><aff id="aff6"><institution content-type="dept">Department of Neurosciences, Faculty of Medicine</institution>, <institution>Université de Montréal</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-15772"><name><surname>Chiu</surname><given-names>Isaac M</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>v.ramaglia@utoronto.ca</email> (VR);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>08</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e48051</elocation-id><history><date date-type="received"><day>29</day><month>04</month><year>2019</year></date><date date-type="accepted"><day>01</day><month>08</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Ramaglia et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Ramaglia et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-48051-v1.pdf"/><abstract><p>Multiple Sclerosis (MS) is characterized by demyelinated and inflammatory lesions in the brain and spinal cord that are highly variable in terms of cellular content. Here we used imaging mass cytometry (IMC) to enable the simultaneous imaging of 15+ proteins within staged MS lesions. To test the potential for IMC to discriminate between different types of lesions, we selected a case with severe rebound MS disease activity after natalizumab cessation. With post-acquisition analysis pipelines we were able to: (1) Discriminate demyelinating macrophages from the resident microglial pool; (2) Determine which types of lymphocytes reside closest to blood vessels; (3) Identify multiple subsets of T and B cells, and (4) Ascertain dynamics of T cell phenotypes vis-à-vis lesion type and location. We propose that IMC will enable a comprehensive analysis of single-cell phenotypes, their functional states and cell-cell interactions in relation to lesion morphometry and demyelinating activity in MS patients.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000890</institution-id><institution>National Multiple Sclerosis Society</institution></institution-wrap></funding-source><award-id>RR-1602-07777</award-id><principal-award-recipient><name><surname>Ramaglia</surname><given-names>Valeria</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000261</institution-id><institution>Multiple Sclerosis Society of Canada</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gommerman</surname><given-names>Jennifer L</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000261</institution-id><institution>Multiple Sclerosis Society of Canada</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Prat</surname><given-names>Alexandre</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Valeria Ramaglia, received a consulting honorarium from EMD Serono.</p></fn><fn fn-type="conflict" id="conf3"><p>Olga Ornatsky, is an employee of Fluidigm Inc.</p></fn><fn fn-type="conflict" id="conf4"><p>Eric C Swanson, is an employee of Fluidigm Inc.</p></fn><fn fn-type="conflict" id="conf5"><p>Jennifer L Gommerman, is a consultant for Roche (Canada) and currently holds grants with Novartis, EMD Serono, and Roche.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This work included the use of post-mortem brain tissue. Written consent for post-mortem donation of the CNS to research from the MS donor was obtained (ethics committee approval number BH.07.001).Ethical approval for the use of post-mortem brain tissue from the control donor of the Netherlands Brain Bank was obtained (VU Medical Center ethic committee approval Reference number 2009/148)</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated and analysed during this study are included in the manuscript and supporting files. Source data file has been provided for Figure 7.</p></sec><supplementary-material><ext-link xlink:href="elife-48051-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>